A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent <i>Clostridioides difficile</i> Infection
<i>Clostridioides difficile</i> infection (CDI) is an intestinal infection that causes morbidity and mortality and places significant burden and cost on the healthcare system, especially in recurrent cases. Antibiotic overuse is well recognized as the leading cause of CDI in high-risk pa...
Saved in:
Main Authors: | Yifan Wang (Author), Aaron Hunt (Author), Larry Danziger (Author), Emily N. Drwiega (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021) -
Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?
by: Krishna Vedala, et al.
Published: (2021) -
Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
by: Azimirad M, et al.
Published: (2020) -
The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for <i>Clostridioides difficile</i> Infection in Italy
by: Maria Chiara de Stefano, et al.
Published: (2022) -
Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
by: Azimirad M, et al.
Published: (2022)